N-[4-[(4S,7S,10S,13R)-4-[(2S)-butan-2-yl]-7-[(1-methoxyindol-3-yl)methyl]-3,6,9,12-tetraoxo-1,5,8,11-tetrazabicyclo[11.4.0]heptadecan-10-yl]butyl]acetamide

InChIKey	`YOZGZRIRUIFINH-VHKXXLIKSA-N`
Compound Name	N-[4-[(4S,7S,10S,13R)-4-[(2S)-butan-2-yl]-7-[(1-methoxyindol-3-yl)methyl]-3,6,9,12-tetraoxo-1,5,8,11-tetrazabicyclo[11.4.0]heptadecan-10-yl]butyl]acetamide
Canonical SMILES	`CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2cn(OC)c3ccccc23)NC(=O)[C@H](CCCCNC(C)=O)NC(=O)[C@H]2CCCCN2CC1=O`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	N/A
Source	TTD_MultiTarget

2D Structure

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P56524	HDAC4	Homo sapiens	Human	PF12203 PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q02161	RHD	Homo sapiens	Human	PF00909	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q13547	HDAC1	Homo sapiens	Human	PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget
Q92769	HDAC2	Homo sapiens	Human	PF00850	Clinical	TTD_MultiTarget	TTD_MultiTarget